One of the lowest paid CEOs in pharma—and one of the only woman leading a top-tier giant—is set to receive up to $27.2 ...

The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. While it revealed (PDF) that Walmsley took a 16% pay cut in 2024, it also laid out a new compensation ...

Emma Walmsley has also been busy shaking up the company and has replaced 50 top managers, around 40% of the company’s management. Pfizer said in October that it is considering selling its ...

Dame Emma Walmsley, chief executive of drugs giant GSK, received £10.6million in salary and bonuses in 2024 and under a new pay structure could receive as much as £21.6million for this year.

Walmsley has also refocused the company’s R&D efforts in cancer, something that was deprioritised under Witty, who decided to give the company’s portfolio of approved oncology drugs to ...